The Genetic Variations of ESR1 Gene are Associated with Blood Pressure Traits in the Korean Women

  • Jin, Hyun-Seok (Department of Medical Genetics, School of Medicine, Ajou University) ;
  • Sull, Jae-Woong (Department of Biomedical Laboratory Science, College of Health Science, Eulji University) ;
  • Eom, Yong-Bin (Department of Biomedical Laboratory Science, Korea Nazarene University)
  • Received : 2012.04.09
  • Accepted : 2012.06.07
  • Published : 2012.06.30

Abstract

Hypertension is a complex disease that results from the interaction of genetic and environmental influences and heritability is influenced by about one-third to one-half. However, the specific genetic variants determining risk for hypertension are still largely unknown. Here, we performed association analysis to elucidate the possible relations of genetic polymorphisms in ESR1 gene with blood pressure traits. By examining genotype data of a total of 3,804 women in the Korean Association REsource (KARE) study, we discovered the ESR1 gene polymorphisms are associated with blood pressure and hypertension. The highest significant polymorphisms were rs2982571 (${\beta}=-1.56$, $P=6.8{\times}10^{-3}$) with systolic blood pressure (SBP), rs9322335 (${\beta}=-0.61$, P=0.013) with diastolic blood pressure (DBP), and rs851985 (OR=0.78, CI: 0.65~0.94, $P=8.6{\times}10^{-3}$) with hypertension. In the 5 SNPs (rs2982571, rs851985, rs851983, rs851981, and rs851980), their ${\beta}$-values in SBP and/or DBP showed consistent trends with the odds ratios (ORs) of hypertension, and these 5 SNPs were composed with one LD block. Consequently, we found statistically significant SNPs in ESR1 gene that are associated with both blood pressure and hypertension traits. These results suggested that the individuals with the minor alleles of the 5 SNPs in the ESR1 gene may be less susceptible to the development of hypertension in the Korean women.

Keywords

References

  1. Barrett JG, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005. 21: 263-265. https://doi.org/10.1093/bioinformatics/bth457
  2. Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal J. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor $\alpha$ but not estrogen receptor $\beta$. Circulation 2001. 103: 423-428. https://doi.org/10.1161/01.CIR.103.3.423
  3. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, Park M, Cha SH, Kim JW, Han BG, Min H, Ahn Y, Park MS, Han HR, Jang HY, Cho EY, Lee JE, Cho NH, Shin C, Park T, Park JW, Lee JK, Cardon L, Clarke G, McCarthy MI, Lee JY, Oh B, Kim HL. A large-scale genomewide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet. 2009. 41: 527-534. https://doi.org/10.1038/ng.357
  4. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002. 53: 688-708. https://doi.org/10.1016/S0008-6363(01)00527-2
  5. Figtree GA, Kindmark A, Lind L, Grundberg E, Speller B, Robinson BG, Channon KM, Watkins H. Novel estrogen receptor alpha promoter polymorphism increases ventricular hypertrophic response to hypertension. J Steroid Biochem Mol Biol. 2007. 103: 110-118. https://doi.org/10.1016/j.jsbmb.2006.09.035
  6. Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 1998. 98: 1158-1163. https://doi.org/10.1161/01.CIR.98.12.1158
  7. Harrison-Bernard LM, Raij L. Postmenopausal hypertension. Curr Hypertens Rep. 2000. 2: 202-207. https://doi.org/10.1007/s11906-000-0083-2
  8. Hedrick PW. Gametic disequilibrium measures: Proceed with caution. Genetics. 1987. 117: 331-341.
  9. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992. 71: 169-180. https://doi.org/10.1016/0092-8674(92)90275-H
  10. Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. 2004. 89: 3907-3913. https://doi.org/10.1210/jc.2004-0015
  11. Kalantaridou SN, Naka KK, Bechlioulis A, Makrigiannakis A, Michalis L, Chrousos GP. Premature ovarian failure, endothelial dysfunction and estrogen-progestrogen replacement. Trends Endocrinol Metab. 2006. 17: 101-109. https://doi.org/10.1016/j.tem.2006.02.003
  12. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994. 89: 1943-1950. https://doi.org/10.1161/01.CIR.89.5.1943
  13. Maruyama H, Toji H, Harrington CR, Sasaki K, Izumi Y, Ohnuma T. Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol. 2000. 57: 236-240. https://doi.org/10.1001/archneur.57.2.236
  14. Matsubara Y, Murata M, Kawano K, Zama T, Aoki N, Yoshino H. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol. 1997. 17: 3006-3012. https://doi.org/10.1161/01.ATV.17.11.3006
  15. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999. 340: 1801-1811. https://doi.org/10.1056/NEJM199906103402306
  16. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. A J Cardiol. 2002. 90: 3F-6F. https://doi.org/10.1016/S0002-9149(02)02418-9
  17. Moriarty K, Kim KH, Bender JR. Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 2006. 147: 5557-5563. https://doi.org/10.1210/en.2006-0729
  18. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon R, Mendelsohn ME. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res. 2002. 90: 1087-1092. https://doi.org/10.1161/01.RES.0000021114.92282.FA
  19. Parker MG, Arbuckle N, Dauvois S, Danielian P, White R. Structure and function of the estrogen receptor. Ann NY Acad Sci. 1993. 684: 119-126. https://doi.org/10.1111/j.1749-6632.1993.tb32276.x
  20. Pendaries C, Darblade B, Rochaix P. The AF-1 activation-function of ER-$\alpha$ may be despensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA. 2002. 99: 2205-2210. https://doi.org/10.1073/pnas.042688499
  21. Peter I, Shearman AM, Zucker DR, Schmid CH, Demissie S, Cupples LA, Larson MG, Vasan RS, D'Agostino RB, Karas RH, Mendelsohn ME, Housman DE, Levy D. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens. 2005. 23: 2193-2200. https://doi.org/10.1097/01.hjh.0000188728.66183.92
  22. Rabbee N, Speed TP. A genotype calling algorithm for Affymetrix SNP arrays. Bioinformatics 2006. 22: 7-12. https://doi.org/10.1093/bioinformatics/bti741
  23. Snieder H, Harshfield GA, Treiber FA. Heritability of blood pressure and hemodynamics in African- and European-American youth. Hypertension 2003. 41: 1196-1201. https://doi.org/10.1161/01.HYP.0000072269.19820.0D
  24. Sumino H, Ichikawa S, Kasama S, Takahashi T, Kumakura H, Takayama Y. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women. Atherosclerosis 2006. 189: 436-442. https://doi.org/10.1016/j.atherosclerosis.2005.12.030
  25. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996. 94: 727-733. https://doi.org/10.1161/01.CIR.94.4.727
  26. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002. 295: 505-508. https://doi.org/10.1126/science.1065250